Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Joshua L. Gowin

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-RAD General Operations
Phone303/724-3769

    Collapse Research 
    Collapse research activities and funding
    R00AA024778     (GOWIN, JOSHUA LEIGH)Sep 1, 2018 - Aug 31, 2021
    NIH
    Neural Correlates of Emotion Regulation in Youth at Risk for Alcoholism
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rieck J, Wrobel J, Porras AR, McRae K, Gowin JL. Neural signatures of emotion regulation. Sci Rep. 2024 01 20; 14(1):1775. PMID: 38245590.
      View in: PubMed
    2. Sloan ME, Sanches M, Tanabe J, Gowin JL. Delay discounting and family history of psychopathology in children ages 9-11. Sci Rep. 2023 12 11; 13(1):21977. PMID: 38081908.
      View in: PubMed
    3. Gowin JL, Sloan ME, Kirk-Provencher KT, Rosenblatt SL, Penner AE, Stangl BL, Byrd ND, Swan JE, Ramchandani VA. Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users. J Psychopharmacol. 2023 09; 37(9):937-941. PMID: 37530456.
      View in: PubMed
    4. Kirk-Provencher KT, Hakimi RH, Andereas K, Penner AE, Gowin JL. NEURAL RESPONSE TO THREAT AND REWARD AMONG YOUNG ADULTS AT RISK FOR ALCOHOL USE DISORDER. medRxiv. 2023 Jul 24. PMID: 37546975.
      View in: PubMed
    5. Kirk-Provencher KT, Penner AE, McRae K, Gowin JL. Emotion regulation in young adults with family history of harmful alcohol use: A fMRI study. Drug Alcohol Depend. 2023 02 01; 243:109752. PMID: 36610254.
      View in: PubMed
    6. Sloan ME, Sells JR, Vaughan CL, Morris JK, Ortega NE, Sundar S, Soundararajan S, Stangl BL, Gowin J, Chawla S, Diazgranados N, McKee SA, Waters A, Ramchandani VA. Modeling ability to resist alcohol in the human laboratory: A pilot study. Drug Alcohol Depend Rep. 2022 Dec; 5:100105. PMID: 36844167.
      View in: PubMed
    7. Stellern J, Xiao KB, Grennell E, Sanches M, Gowin JL, Sloan ME. Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction. 2023 01; 118(1):30-47. PMID: 35851975.
      View in: PubMed
    8. Gowin JL, Sloan ME, Morris JK, Schwandt ML, Diazgranados N, Ramchandani VA. Characteristics Associated With High-Intensity Binge Drinking in Alcohol Use Disorder. Front Psychol. 2021; 12:750395. PMID: 34744927.
      View in: PubMed
    9. Penner AE, White E, Stoddard J, Gowin JL. The Neural Circuitry of Reward During Sustained Threat. Cogn Affect Behav Neurosci. 2022 02; 22(1):134-144. PMID: 34435281.
      View in: PubMed
    10. Gowin JL, Manza P, Ramchandani VA, Volkow ND. Neuropsychosocial markers of binge drinking in young adults. Mol Psychiatry. 2021 09; 26(9):4931-4943. PMID: 32398720.
      View in: PubMed
    11. Janakiraman R, Gowin JL, Sloan ME, Schwandt ML, Diazgranados N, Ramchandani VA, Kwako LE. History of suicidality and alcohol craving trajectories during inpatient treatment for alcohol use disorder. Drug Alcohol Depend. 2020 04 01; 209:107918. PMID: 32092637.
      View in: PubMed
    12. Regner MF, Tregellas J, Kluger B, Wylie K, Gowin JL, Tanabe J. The insula in nicotine use disorder: Functional neuroimaging and implications for neuromodulation. Neurosci Biobehav Rev. 2019 08; 103:414-424. PMID: 31207255.
      View in: PubMed
    13. Tanabe J, Regner M, Sakai J, Martinez D, Gowin J. Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment. Br J Radiol. 2019 Sep; 92(1101):20180942. PMID: 30855982.
      View in: PubMed
    14. Ernst M, Gowin JL, Gaillard C, Philips RT, Grillon C. Sketching the Power of Machine Learning to Decrypt a Neural Systems Model of Behavior. Brain Sci. 2019 Mar 20; 9(3). PMID: 30897793.
      View in: PubMed
    15. Sloan ME, Gowin JL, Janakiraman R, Ester CD, Stoddard J, Stangl B, Ramchandani VA. High-risk social drinkers and heavy drinkers display similar rates of alcohol consumption. Addict Biol. 2020 03; 25(2):e12734. PMID: 30821409.
      View in: PubMed
    16. Gowin JL, Ernst M, Ball T, May AC, Sloan ME, Tapert SF, Paulus MP. Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models. Neuroimage Clin. 2019; 21:101676. PMID: 30665102.
      View in: PubMed
    17. Gowin J, Sloan ME, Swan JE, Momenan R, Ramchandani VA. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology. Psychopharmacology (Berl). 2019 Feb; 236(2):775-785. PMID: 30456539.
      View in: PubMed
    18. Sloan ME, Grant CW, Gowin JL, Ramchandani VA, Le Foll B. Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies. Acta Pharmacol Sin. 2019 Mar; 40(3):342-350. PMID: 30166624.
      View in: PubMed
    19. Fede SJ, Gowin JL, Manza P. An Eye for an Eye: Neural Correlates of the Preference for Punishment-Based Justice. J Neurosci. 2018 08 29; 38(35):7559-7561. PMID: 30158297.
      View in: PubMed
    20. Suchting R, Gowin JL, Green CE, Walss-Bass C, Lane SD. Genetic and Psychosocial Predictors of Aggression: Variable Selection and Model Building With Component-Wise Gradient Boosting. Front Behav Neurosci. 2018; 12:89. PMID: 29867390.
      View in: PubMed
    21. Sloan ME, Klepp TD, Gowin JL, Swan JE, Sun H, Stangl BL, Ramchandani VA. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. Neuropsychopharmacology. 2018 06; 43(7):1530-1538. PMID: 29497164.
      View in: PubMed
    22. Gowin JL, Sloan ME, Ramchandani VA, Paulus MP, Lane SD. Differences in decision-making as a function of drug of choice. Pharmacol Biochem Behav. 2018 01; 164:118-124. PMID: 28927583.
      View in: PubMed
    23. Gowin JL, Sloan ME, Stangl BL, Vatsalya V, Ramchandani VA. Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption. Am J Psychiatry. 2017 11 01; 174(11):1094-1101. PMID: 28774194.
      View in: PubMed
    24. Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B. The endocannabinoid system as a target for addiction treatment: Trials and tribulations. Neuropharmacology. 2017 Sep 15; 124:73-83. PMID: 28564576.
      View in: PubMed
    25. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Corrigendum to "Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse" [Drug and Alcohol Dependence 152 (2015) 93-101]. Drug Alcohol Depend. 2017 06 01; 175:255. PMID: 28431752.
      View in: PubMed
    26. Sloan ME, Gowin JL, Yan J, Schwandt ML, Spagnolo PA, Sun H, Hodgkinson CA, Goldman D, Ramchandani VA. Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. Addict Biol. 2018 01; 23(1):474-484. PMID: 28150397.
      View in: PubMed
    27. Gowin JL, May AC, Wittmann M, Tapert SF, Paulus MP. Doubling down: increased risk-taking behavior following a loss by individuals with cocaine use disorder is associated with striatal and anterior cingulate dysfunction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan; 2(1):94-103. PMID: 28164168.
      View in: PubMed
    28. Gowin JL, Vatsalya V, Westman JG, Schwandt ML, Bartlett S, Heilig M, Momenan R, Ramchandani VA. The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers. Alcohol Clin Exp Res. 2016 05; 40(5):979-87. PMID: 27062270.
      View in: PubMed
    29. Pariyadath V, Gowin JL, Stein EA. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks. Prog Brain Res. 2016; 224:155-73. PMID: 26822358.
      View in: PubMed
    30. Vatsalya V, Gowin JL, Schwandt ML, Momenan R, Coe MA, Cooke ME, Hommer DW, Bartlett S, Heilig M, Ramchandani VA. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers. Int J Neuropsychopharmacol. 2015 Jul 25; 18(12). PMID: 26209857.
      View in: PubMed
    31. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse. Drug Alcohol Depend. 2015 Jul 01; 152:93-101. PMID: 25977206.
      View in: PubMed
    32. Kose S, Steinberg JL, Moeller FG, Gowin JL, Zuniga E, Kamdar ZN, Schmitz JM, Lane SD. Neural correlates of impulsive aggressive behavior in subjects with a history of alcohol dependence. Behav Neurosci. 2015 Apr; 129(2):183-96. PMID: 25664566.
      View in: PubMed
    33. Gowin JL, Harl? KM, Stewart JL, Wittmann M, Tapert SF, Paulus MP. Attenuated insular processing during risk predicts relapse in early abstinent methamphetamine-dependent individuals. Neuropsychopharmacology. 2014 May; 39(6):1379-87. PMID: 24317375.
      View in: PubMed
    34. Gowin JL, Stewart JL, May AC, Ball TM, Wittmann M, Tapert SF, Paulus MP. Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact. Addiction. 2014 Feb; 109(2):237-47. PMID: 24033715.
      View in: PubMed
    35. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):13-21. PMID: 23623507.
      View in: PubMed
    36. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. The role of cortisol and psychopathy in the cycle of violence. Psychopharmacology (Berl). 2013 Jun; 227(4):661-72. PMID: 23371492.
      View in: PubMed
    37. Alcorn JL, Gowin JL, Green CE, Swann AC, Moeller FG, Lane SD. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J Neuropsychiatry Clin Neurosci. 2013; 25(3):229-32. PMID: 24026715.
      View in: PubMed
    38. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93. PMID: 21730016.
      View in: PubMed
    39. Gowin JL, Swann AC, Moeller FG, Lane SD. Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31. PMID: 20407761.
      View in: PubMed
    40. Lane SD, Gowin JL. GABAergic modulation of human social interaction in a prisoner's dilemma model by acute administration of alprazolam. Behav Pharmacol. 2009 Oct; 20(7):657-61. PMID: 19667972.
      View in: PubMed
    41. Lane SD, Gowin JL, Green CE, Steinberg JL, Moeller F, Cherek DR. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior. Pharmacol Biochem Behav. 2009 Apr; 92(2):357-62. PMID: 19353809.
      View in: PubMed
    Gowin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (158) concept(s)
    _
    Co-Authors Expand Description
    See all (7) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)